ScholarIQanswers from OpenAlex
Servier (France)
InstitutionResearch output, impact & collaborations
Servier (France) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Servier (France)?
ScholarIQrecord summary
Servier (France) is a research organisation in Neuilly-sur-Seine, FR. OpenAlex records 4,405 works and 520,905 citations for it. 1,354 researchers list it as their most recent affiliation.
How many works does Servier (France) have?
ScholarIQindexed works
Servier (France) has 4,405 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Servier (France) have?
ScholarIQcitation count
Servier (France) has 520,905 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Servier (France)?
ScholarIQresearcher count
Servier (France) has 1,354 researchers in the ScholarIQ index.
What is the average h-index at Servier (France)?
ScholarIQavg h-index
Servier (France) has an average h-index of 28 in OpenAlex.
What is the ROR of Servier (France)?
ScholarIQror
The ROR for Servier (France) is on the source record.
What is the OpenAlex record for Servier (France)?
ScholarIQopenalex
The OpenAlex for Servier (France) is on the source record.
Who are the most-cited researchers behind Servier (France)?
ScholarIQtop researchers by citations
What are the most-cited papers on Servier (France)?
ScholarIQmost cited works
A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer
Paul E. Goss, James N. Ingle, Silvana Martino, Nicholas J. Robert, Hyman B. Muss, Martine Piccart, Monica Castiglione, Dongsheng Tu, Lois E. Shepherd, Kathleen I. Pritchard, Robert B. Livingston, Nancy E. Davidson, Larry Norton, Edith A. Perez, Jeffrey S. Abrams, Patrick Therasse, Michael Palmer, Joseph L. Pater
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
Johan Vansteenkiste, Byoung Chul Cho, Tõnu Vanakesa, Tommaso De Pas, M. Zieliński, Moon Soo Kim, Jacek Jassem, Masahiro Yoshimura, Jubrail Dahabreh, Haruhiku Nakayama, Libor Havel, Haruhiko Kondo, Tetsuya Mitsudomi, Paul Zarogoulidis, Oleg Gladkov, Katalin Udud, Hirohito Tada, Hans Hoffman, Anders Bugge, Paul Taylor, Emilio Esteban Gonzalez, Mei Lin Liao, Jianxing He, Jean-Louis Pujol, Jamila Louahed, Muriel Debois, Vincent Brichard, C. Debruyne, Patrick Therasse, Nasser K. Altorki
How much of the research on Servier (France) is open access?
ScholarIQopen access share
100%OPEN ACCESS